Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification
Ying Wang, Xiaomei He, Chunshi Li, et al.
European Journal of Medicinal Chemistry (2020) Vol. 193, pp. 112235-112235
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Cytochrome P450 Enzymes and Drug Metabolism in Humans
Mingzhe Zhao, Jingsong Ma, Mo Li, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12808-12808
Open Access | Times Cited: 506
Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy
Rongyan Zhao, Jia Fu, Lingjuan Zhu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 74
Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes
Yeo‐Jung Kwon, Sangyun Shin, Young‐Jin Chun
Archives of Pharmacal Research (2021) Vol. 44, Iss. 1, pp. 63-83
Closed Access | Times Cited: 55
Progress of molecular imprinting technique for enantioseparation of chiral drugs in recent ten years
Junli Pu, Hongwei Wang, Chao Huang, et al.
Journal of Chromatography A (2022) Vol. 1668, pp. 462914-462914
Closed Access | Times Cited: 46
Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp
Mohamad Ali Hijazi, André Gessner, Nahed El‐Najjar
Cancers (2023) Vol. 15, Iss. 12, pp. 3199-3199
Open Access | Times Cited: 16
Combining transcriptomic analysis and network pharmacology to explore the mechanism by which Shaofu Zhuyu decoction improves diabetes mellitus erectile dysfunction
Yinhui Mao, Juntao Sun, Zhuo Wang, et al.
Phytomedicine (2023) Vol. 119, pp. 155006-155006
Closed Access | Times Cited: 15
Identification of Epinastine as CD96/PVR inhibitor for cancer immunotherapy
Xiangrui Zhang, Lihan Zhang, Beibei Li, et al.
BMC Biology (2025) Vol. 23, Iss. 1
Open Access
Heme-thiolate monooxygenase cytochrome P450 1B1, an old dog with many new tricks
Jong-Won Kim, Hung‐Chun Tung, Bin Yang, et al.
Pharmacological Reviews (2025) Vol. 77, Iss. 3, pp. 100045-100045
Closed Access
Hypertums A−J, bioactive polycyclic polyprenylated acylphloroglucinols with diverse skeletons from Hypericum perforatum L. (St. John's Wort)
Wu-Yang Liu, Linlin Gao, Wei Zhou, et al.
Phytochemistry (2025), pp. 114450-114450
Closed Access
Design, synthesis and biological evaluation of novel benzofuran derivatives as potent LSD1 inhibitors
Xiangyu Zhang, Hai‐Lan Huang, Ziheng Zhang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 220, pp. 113501-113501
Open Access | Times Cited: 27
Computer‐assisted Methods and Tools for Structure‐ and Ligand‐based Drug Design
Saurav Kumar Mishra, Sneha Roy, Tabsum Chhetri, et al.
(2024), pp. 69-95
Closed Access | Times Cited: 3
CYP1B1 as a therapeutic target in cardio-oncology
Alexa N. Carrera, Marianne Grant, Beshay N. Zordoky
Clinical Science (2020) Vol. 134, Iss. 21, pp. 2897-2927
Open Access | Times Cited: 30
Structure-based virtual screening discovers novel PKMYT1 inhibitors
Haoyu Zhang, Jinyu Yu, Ziheng Yang, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 9, pp. 3114-3124
Closed Access | Times Cited: 2
New Perspectives of CYP1B1 Inhibitors in the Light of Molecular Studies
Renata Mikstacka, Zbigniew Dutkiewicz
Processes (2021) Vol. 9, Iss. 5, pp. 817-817
Open Access | Times Cited: 19
Dearomative [4 + 2] annulations between 3-nitroindoles and enals through oxidative N-heterocyclic carbene catalysis
Hua Huang, Qing‐Zhu Li, Yanqing Liu, et al.
Organic Chemistry Frontiers (2020) Vol. 7, Iss. 23, pp. 3862-3867
Closed Access | Times Cited: 18
Screening and identifying of α‐amylase inhibitors from medicine food homology plants: Insights from computational analysis and experimental studies
Chao Jiang, Li Wang, Jiajia Shao, et al.
Journal of Food Biochemistry (2020) Vol. 44, Iss. 12
Open Access | Times Cited: 18
Novel natural scaffold as hURAT1 inhibitor identified by 3D-shape-based, docking-based virtual screening approach and biological evaluation
Xinhua Chen, Zean Zhao, Jiajun Luo, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105444-105444
Closed Access | Times Cited: 14
Structure-Based Drug Design and Synthesis of Novel N-Aryl-2,4-bithiazole-2-amine CYP1B1-Selective Inhibitors in Overcoming Taxol Resistance in A549 Cells
Jianping Mao, Dong Wang, Ping Xu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16451-16480
Closed Access | Times Cited: 10
CYP1B1: A Promising Target in Cancer Drug Discovery
Marciéli Fábris, Mariana Luiza Silva, Kaio Maciel de Santiago-Silva, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 9, pp. 981-988
Closed Access | Times Cited: 5
Comprehensive analysis of Indacaterol and Theophylline molecules: insights from DFT, FTIR, Raman, UV, molecular docking, and ADMET studies
Güldane Sena Çatal, Neslihan Kaya Kınaytürk
Spectroscopy Letters (2024) Vol. 57, Iss. 9, pp. 499-526
Closed Access | Times Cited: 1
Configurational Alteration Results in Change in Hepatotoxicity of Asarone
Guode Zhao, Yufei Ma, Xu Wang, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 71, Iss. 1, pp. 884-894
Closed Access | Times Cited: 7
Intermolecular insights into allosteric inhibition of histone lysine-specific demethylase 1
Xiangyu Zhang, Yixiang Sun, Ziheng Zhang, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2021) Vol. 1865, Iss. 11, pp. 129990-129990
Closed Access | Times Cited: 10
Exploration of shared TF-miRNA‒mRNA and mRNA-RBP-pseudogene networks in type 2 diabetes mellitus and breast cancer
Tong Wu, Gu Wenze, Li-rong Hong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Identification of potential benzoxazolinones as CYP1B1 inhibitors via molecular docking, dynamics, waterswap, and in vitro analysis
Baddipadige Raju, Himanshu Verma, Gera Narendra, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 26, pp. 12339-12349
Closed Access | Times Cited: 3
Hepatic RNA adduction derived from metabolic activation of retrorsine in vitro and in vivo
Weiwei Li, Ting Cheng, Tingting Jiang, et al.
Chemico-Biological Interactions (2022) Vol. 365, pp. 110047-110047
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top